Skip to content
TrackPodcasts
healthJun 4, 202445:30pending

FLOW trial and GLP-1 cost rant

Docs Who Lift

About this episode

Drs. Karl and Spencer discuss the recent FLOW trial where semaglutide was found to be kidney protective. They also go off about the costs of these medicines and what to do (including compounding considerations).


Click here to see the study


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Docs Who Lift publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

FLOW trial and GLP-1 cost rant

Docs Who Lift

0:00
45:30

More episodes

More from Docs Who Lift

View all episodes →